Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice

Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice

Bibliographic Details
Main Authors:	Yanmin Chang, Yi Yao, Rong Ma, Zemin Wang, Junjie Hu, Yanqing Wu, Xingjun Jiang, Lulu Li, Gang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Neuroscience
Subjects:	Dl-3-n-butylphthalide tau P301S cognitive deficits neuroinflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2021.716049/full

Similar Items

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
by: Yanmin Chang, et al.
Published: (2021-02-01)

Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
by: Yajing Chen, et al.
Published: (2019-02-01)

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
by: Yajing Chen, et al.
Published: (2021-07-01)

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
by: Rongfang Que, et al.
Published: (2021-12-01)

DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation
by: Bingjiang Han, et al.
Published: (2021-06-01)

The neuroprotective effect of Dl-3-n-butylphthalide in epileptic rats via inhibiting endoplasmic reticulum stress
by: Shuang Tian, et al.
Published: (2023-01-01)

DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress
by: Hui Zhang, et al.
Published: (2023-01-01)

DL-3-n-butylphthalide promotes hippocampal neurogenesis and reduces mossy fiber sprouting in chronic temporal lobe epilepsy rats
by: Shanshan Zhao, et al.
Published: (2022-01-01)

Long-Term DL-3-n-Butylphthalide Treatment Alleviates Cognitive Impairment Correlate With Improving Synaptic Plasticity in SAMP8 Mice
by: Chaonan Lv, et al.
Published: (2018-07-01)

Dl-3-n-Butylphthalide Reduced Neuroinflammation by Inhibiting Inflammasome in Microglia in Mice after Middle Cerebral Artery Occlusion
by: Mengdi Liu, et al.
Published: (2022-08-01)

Dl-3-n-Butylphthalide Alleviates Demyelination and Improves Cognitive Function by Promoting Mitochondrial Dynamics in White Matter Lesions
by: Yiwei Feng, et al.
Published: (2021-03-01)

DL-3-n-butylphthalide attenuates doxorubicin-induced acute cardiotoxicity via Nrf2/HO-1 signaling pathway
by: Dengke Li, et al.
Published: (2024-03-01)

Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion
by: Ting Zhu, et al.
Published: (2024-02-01)

DL-3n-Butylphthalide Improves Blood–Brain Barrier Integrity in Rat After Middle Cerebral Artery Occlusion
by: Muyassar Mamtilahun, et al.
Published: (2021-01-01)

Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis
by: Xiaochao Tian, et al.
Published: (2017-06-01)

Effect of Dl-3-n-butylphthalide on mitochondrial Cox7c in models of cerebral ischemia/reperfusion injury
by: Jingjing Jia, et al.
Published: (2023-02-01)

Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson’s rats
by: Jiawei Wang, et al.
Published: (2024-04-01)

Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
by: Jingyu Xu, et al.
Published: (2021-08-01)

Dl-3-n-Butylphthalide Treatment Enhances Hemodynamics and Ameliorates Memory Deficits in Rats with Chronic Cerebral Hypoperfusion
by: Zhilin Xiong, et al.
Published: (2017-07-01)

Protocol of End-PSCI trial: a multicenter, randomized controlled trial to evaluate the effects of DL-3-n-butylphthalide on delayed-onset post stroke cognitive impairment
by: Ziyu Liu, et al.
Published: (2022-11-01)

Dl-3-n-butylphthalide inhibits phenytoin-induced neuronal apoptosis in rat hippocampus and cerebellum
by: Junmin Chen, Na Liu, Xiaopeng Wang, Yanying Zhao, Junna He, Lan Yang, Qian Sun, Jing Zhao, Linjing Wang, Lei Chen
Published: (2019-09-01)

Dl-3-N-Butylphthalide Presents Anti-Cancer Activity in Lung Cancer by Targeting PD-1/PD-L1 Signaling
by: Jiang Q, et al.
Published: (2021-11-01)

Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
by: Zefeng Tan, et al.
Published: (2021-09-01)

Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective
by: Jianchun Li, et al.
Published: (2024-02-01)

Corrigendum: Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
by: Zefeng Tan, et al.
Published: (2021-11-01)

Neuroprotective effect of Dl-3-n-butylphthalide against ischemia–reperfusion injury is mediated by ferroptosis regulation via the SLC7A11/GSH/GPX4 pathway and the attenuation of blood–brain barrier disruption
by: Shuangli Xu, et al.
Published: (2023-02-01)

Biochemical distribution of tau protein in synaptosomal fraction of transgenic mice expressing human P301L tau
by: Naruhiko eSahara, et al.
Published: (2014-03-01)

UPLC-Q-TOF-MS profiling of the hippocampus reveals metabolite biomarkers for the impact of Dl-3-n-butylphthalide on the lipopolysaccharide-induced rat model of depression
by: Geng C, et al.
Published: (2019-07-01)

Dl-3-n-butylphthalide attenuates H2O2-induced oxidative damage of human umbilical vein and umbilical artery endothelial cells
by: YANG Xiao-li, WANG Zheng, ZHANG Yan-ru, JI Jing-jing, WANG Meng-shuai
Published: (2021-10-01)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
by: Florian Eckenweber, et al.
Published: (2020-07-01)

DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials
by: Huan Wang, et al.
Published: (2022-09-01)

The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease
by: Yao Sun, et al.
Published: (2020-02-01)

DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study
by: Dawei Chen, et al.
Published: (2020-05-01)

Proteomic Analysis of Protective Effects of Dl-3-n-Butylphthalide against mpp + -Induced Toxicity via downregulating P53 pathway in N2A Cells
by: Yuan Zhao, et al.
Published: (2023-01-01)

Unveiling the potential of Butylphthalide: inhibiting osteoclastogenesis and preventing bone loss
by: Feng Yanbin, et al.
Published: (2024-02-01)

Dl-3-n-Butylphthalide Reduces Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion Through GDNF/GFRα1/Ret Signaling Preventing Hippocampal Neuron Apoptosis
by: Wenxian Li, et al.
Published: (2019-08-01)

DL-3-n-butylphthalide enhances synaptic plasticity in mouse model of brain impairments
by: Qian Ding, et al.
Published: (2022-01-01)

Dl-3-n-Butylphthalide Promotes Remyelination and Suppresses Inflammation by Regulating AMPK/SIRT1 and STAT3/NF-κB Signaling in Chronic Cerebral Hypoperfusion
by: Meixi Li, et al.
Published: (2020-06-01)

Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
by: Manuel Schweighauser, et al.
Published: (2023-10-01)

Butylphthalide Inhibits Autophagy and Promotes Multiterritory Perforator Flap Survival
by: Baolong Li, et al.
Published: (2021-01-01)